Search hospitals > New Jersey > Teaneck
Holy Name Medical Center
Claim this profileTeaneck, New Jersey 07666
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Peripheral Arterial Disease
Conducts research for Ovarian Cancer
Conducts research for Multiple Sclerosis
140 reported clinical trials
13 medical researchers
Summary
Holy Name Medical Center is a medical facility located in Teaneck, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Peripheral Arterial Disease, Ovarian Cancer, Multiple Sclerosis and other specialties. Holy Name Medical Center is involved with conducting 140 clinical trials across 168 conditions. There are 13 research doctors associated with this hospital, such as Yadyra Rivera, Sharyn Lewin, MD, John Rundback, MD, and Jason C. Lee.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 positive
HER2 negative
2Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Yadyra RiveraHoly Name Hospital1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
9 reported clinical trials
16 drugs studied
Sharyn Lewin, MDHoly Name Medical Center4 years of reported clinical research
Studies Fallopian Tube Cancer
Studies Ovarian Cancer
7 reported clinical trials
15 drugs studied
John Rundback, MDHoly Name Medical Center3 years of reported clinical research
Studies Peripheral Vascular Disease
Studies Peripheral Arterial Disease
7 reported clinical trials
9 drugs studied
Jason C. LeeHoly Name Hospital3 years of reported clinical research
Studies Prostate Cancer
Studies Pancreatic Cancer
6 reported clinical trials
25 drugs studied
Clinical Trials running at Holy Name Medical Center
Breast Cancer
Pancreatic Cancer
Pancreatic Carcinoma
Ovarian Cancer
Prostate Cancer
Deep Vein Thrombosis
Critical Limb Ischemia
Fallopian Tube Cancer
Cancer
Post-Thrombotic Syndrome
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Holy Name Medical Center?
Holy Name Medical Center is a medical facility located in Teaneck, New Jersey. This center is recognized for care of Breast Cancer, Cancer, Peripheral Arterial Disease, Ovarian Cancer, Multiple Sclerosis and other specialties. Holy Name Medical Center is involved with conducting 140 clinical trials across 168 conditions. There are 13 research doctors associated with this hospital, such as Yadyra Rivera, Sharyn Lewin, MD, John Rundback, MD, and Jason C. Lee.